| # | Drug | Count |
|---|---|---|
| 0 | AMOXICILLIN | 16 |
| 1 | FUROSEMIDE | 16 |
| 2 | LANSOPRAZOLE | 16 |
| 3 | BISOPROLOL FUMARATE | 15 |
| 4 | SACUBITRIL AND VALSARTAN | 15 |
| 5 | ARIPIPRAZOLE | 12 |
| 6 | ARIPIPRAZOLE ORAL | 12 |
| 7 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 12 |
| 8 | DABIGATRAN ETEXILATE | 12 |
| 9 | VALSARTAN | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | 1 | 0.0667 |
| 1 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 2 | IDARUCIZUMAB | 5 | 0.0035 |
| 3 | CLEVIDIPINE | 1 | 0.0027 |
| 4 | EPTIFIBATIDE | 2 | 0.0026 |
| 5 | CHORIONIC GONADOTROPIN | 1 | 0.0018 |
| 6 | ANDEXANET ALFA | 1 | 0.0014 |
| 7 | MENOTROPINS | 3 | 0.0014 |
| 8 | ALPROSTADIL | 4 | 0.0011 |
| 9 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Angiotensin 2 Receptor Blocker [EPC] | 29 |
| 1 | Corticosteroid [EPC] | 25 |
| 2 | Anti-epileptic Agent [EPC] | 19 |
| 3 | Mood Stabilizer [EPC] | 19 |
| 4 | Proton Pump Inhibitor [EPC] | 17 |
| 5 | Atypical Antipsychotic [EPC] | 16 |
| 6 | Loop Diuretic [EPC] | 16 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 14 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 5 | 0.0035 |
| 1 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 2 | Asparagine-specific Enzyme [EPC] | 3 | 0.0002 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 2 | 0.0002 |
| 5 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 3 | 0.0001 |
| 6 | Integrin Receptor Antagonist [EPC] | 10 | 0.0001 |
| 7 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 8 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 29 | 0.0001 |